Picture of Anika Therapeutics logo

ANIK Anika Therapeutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedSmall CapHigh Flyer

Annual balance sheet for Anika Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments18598.394.486.372.9
Net Total Accounts Receivable
Net Total Receivables23.124.129.834.636
Total Inventory
Prepaid Expenses
Total Current Assets234177169170163
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment73.673.268.67975
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets331366348349271
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities16.336.929.827.931.1
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities42.393.260.563.658.4
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity288272287286212
Total Liabilities & Shareholders' Equity331366348349271
Total Common Shares Outstanding